<html><head></head><body><h1>Leukotrap CP2D Solution</h1><p class="drug-subtitle"><b>Dosage Form:</b> solution<br/></p><ul>
<li>Description</li>
<li>Indications and Usage</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Dosage and Administration</li>
<li>How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">References</li>
</ul><h2>LEUKOTRAP® RC SYSTEM DESCRIPTION</h2><p class="First">The Leukotrap® RC System CP2D/AS-3 Blood Bag Unit with In-Line RC2D Filter and Sampling System is intended for the collection of whole blood and preparation of red blood cells and plasma or red blood cells, plasma, and platelets with pre-storage leukocyte reduction of red blood cells. The fluid pathway is sterile and non-pyrogenic. Steam Sterilized. RX only.</p><h2>Indications and Usage for Leukotrap CP2D Solution</h2><p class="First">Instructions for Use for Systems Containing a Y Sampling Site (YSS) with or without a pre-attached Vacuum Tube Holder or Sample Diversion Pouch (SDP) with a pre-attached Vacuum Tube Holder. See unit foil envelope for specific product code/description being used.</p><p>Figure 1- Diagram of the Complete Product Set</p><h3>I. BLOOD COLLECTION INSTRUCTIONS FORSYSTEMS CONTAINING A Y SAMPLING SITE (YSS) ONLY</h3><p class="First">Figure 2- Donor Line with Y Sampling Site Only</p><p class="First">Note: When using YSS systems with a pre-attached vacuum tube holder, go to Section II.</p><p>Precautions:During sample collection ensure the vacuum tubes are centered within the vacuum tube holder and maintain forward pressure on the vacuum tube. Note:After the last tube is collected, it is recommended that the vacuum tube holder be left in place.</p><p class="First">Continue to "Centrifugation", Section IV, Step 1.</p><h3>II. BLOOD COLLECTION INSTRUCTIONS FORSYSTEMS CONTAINING A Y SAMPLING SITE (YSS) WITH A PRE-ATTACHED VACUUM TUBE HOLDER</h3><p class="First">Figure 3- Donor Line with Y Sampling Site and Pre-attached Vacuum Tube Holder with Lid</p><h3>III. BLOOD COLLECTION INSTRUCTIONS FOR SYSTEMS CONTAINING A SAMPLE DIVERSION POUCH WITH A PRE-ATTACHED VACUUM TUBE HOLDER</h3><p class="First">Figure 4- Donor Line with Sample Diversion Pouch with a Pre-attached Vacuum Tube Holder</p><p class="First">Note: Steps 1 through 4 can be performed in any order.</p><p>While holding the top of the PPD, grasp the tubing below the PPD and pull the donor needle into the PPD with a continuous motion until the needle is completely withdrawn and secured into place.</p><h3>IV. BLOOD PROCESSING INSTRUCTIONS:CENTRIFUGATION</h3><h3>V. BLOOD PROCESSING INSTRUCTIONS: PREPARING SET</h3><p class="First">Note:Prior to expression, ensure tubing between the Y-connector and the filter (non-numbered tubing) is clamped. For efficient processing, the tubing may be clamped prior to removing the unit from the centrifuge bucket.</p><h3>VI. BLOOD PROCESSING INSTRUCTIONS: EXPRESSING PLASMA</h3><p class="First">Notes: If preparing a platelet concentrate, the platelet-rich plasma should be separated from the red blood cells within 8 hours after collection. If preparing Fresh Frozen Plasma, the plasma should be separated from the red blood cells and placed in the freezer at –18 °C or colder within 8 hours after blood collection. If preparing Plasma Frozen within 24 Hours after Phlebotomy, the plasma should be separated from the red blood cells and placed in the freezer at –18 °C or colder within 24 hours after blood collection.</p><h3>VII. BLOOD PROCESSING INSTRUCTIONS: TRANSFERRING ADDITIVE</h3><p class="First">Note:The snap-open closure may be opened prior to hanging the bag containing the AS-3 additive solution for additive transfer, provided the non-numbered tubing between the bag containing the red cells and the filter is clamped.</p><h3>VIII. BLOOD FILTRATION INSTRUCTIONS</h3><h3>IX. QUALITY CONTROL TESTING</h3><h2>Warnings</h2><h2>Precautions</h2><h3>General</h3><h2>Adverse Reactions</h2><p class="First">There are no known potential adverse reactions associated specifically with theLeukotrap® RC System CP2D/AS-3 Blood Bag Unit with In-Line RC2D Filter and Sampling System.</p><h2>Leukotrap CP2D Solution Dosage and Administration</h2><h2>How is Leukotrap CP2D Solution Supplied</h2><p class="First">Each unit consists of:</p><h2>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</h2><p class="First">Figure 5 - Envelope Label</p><p>Figure 6 - Collection Bag Label</p><p>Figure 7 - Additive/Storage Bag Label</p><p>Figure 8 – Platelet/Plasma CLX Bag Label</p><h2>REFERENCES</h2><p class="First">Haemonetics®, Haemonetics The Blood Management Company® and Leukotrap® are trademarks or registered trademarks of Haemonetics Corporation in the US, other countries or both.</p><p>Manufactured for:</p><p>Haemonetics Corporation</p><p>400 Wood Road</p><p>Braintree, MA 02184, USA</p><p>By: Haemonetics Manufacturing Inc.</p><p>1630 Industrial Park Street</p><p>Covina, CA 91722, USA</p><p>www.haemonetics.com</p><p>800-537-2802</p><p>IFU P/N 147129621 (AA)</p><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>